DYAI CEO Mark Emalfarb Shares Insights, $6M Capital Raise, 2024 Outlook etc,. on “The Street Reports Podcast” – Tune In!
Related posts: “Dyadic International Inc. (NASDAQ: DYAI) Advances Biopharmaceutical Innovations and Vaccine Manufacturing Globally” “Dyadic International Inc. (NASDAQ: DYAI): Zacks Small-Cap Research Indicates Valuation at $9.00 per Share” Top 5…
